Newsletter
Transcarent
Transcarent offers employers and health plans a single service for benefits questions, clinical guidance, virtual care, and pharmacy support.
The record
- Vertical
- Care Navigation & Employer Benefits
- Sub-segment
- Health and care navigation for self insured employers
- Product type
- Service
- Stage
- Series C+
- Headquarters
- Denver, Colorado
- Region
- North America
- Founded
- 2020
- Total funding
- $957M
What they do
Transcarent launched in 2020, is headquartered in Denver, and is led by founder and CEO Glen Tullman. Its WayFinding service answers member questions about medical, pharmacy, and point solution benefits, using AI that works alongside health guides and licensed clinicians. Members can reach virtual primary care around the clock, and employers can add programs for pharmacy, weight health, surgery, cancer care, and expert second opinions through 2nd.MD. Transcarent acquired Accolade in 2025. Its main customers are self insured employers. The company reports total funding of $957 million, most recently through a Series D, with investors including General Catalyst and 7wireVentures.
Leadership & founders
Leadership as of 14 November 2026.
- Glen Tullman
Chief Executive Officer
Investors
- General Catalyst
- 7wireVentures
- Jove Equity Partners
In The HealthTech Signal
Related companies
